Works about SPIRONOLACTONE

Results: 855

What you need to know about gender‐affirming healthcare.

Published in:

Emergency Medicine Australasia, 2022, v. 34, n. 3, p. 438, doi. 10.1111/1742-6723.13990

By:

Carroll, Rona;
Bisshop, Fiona

Publication type:

Article

Simultaneous separation and rapid determination of spironolactone and its metabolite canrenone in different pharmaceutical formulations and urinary matrices by capillary zone electrophoresis.

Published in:

Journal of Separation Science, 2016, v. 39, n. 14, p. 2869, doi. 10.1002/jssc.201600255

By:

Li, Lou;
Huang, Yayun;
Zhao, Wenyan;
Zhang, Guangbin;
Zhang, Hongfen;
Chen, Anjia

Publication type:

Article

Polymorph formation from solvate desolvation.

Published in:

Journal of Thermal Analysis & Calorimetry, 2007, v. 90, n. 2, p. 337, doi. 10.1007/s10973-007-8389-9

By:

Nicolaï, Beatrice;
Espeau, P.;
Céolin, R.;
Perrin, M.-A.;
Zaske, L.;
Giovannini, J.;
Leveiller, F.

Publication type:

Article

Thermal behavior of orthorhombic polymorphs I and II of spironolactone.

Published in:

Journal of Thermal Analysis & Calorimetry, 2007, v. 90, n. 2, p. 341, doi. 10.1007/s10973-007-8390-3

By:

Espeau, P.;
Nicolaï, B.;
Céolin, R.;
Perrin, M.;
Zaske, L.;
Giovannini, J.;
Leveiller, F.

Publication type:

Article

Spironolactone improves endothelial dysfunction in ankylosing spondylitis.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 7, p. 1029, doi. 10.1007/s10067-013-2233-3

By:

Syngle, Ashit;
Vohra, Kanchan;
Khichi, Dinesh;
Garg, Nidhi;
Verma, Inderjeet;
Kaur, Ladbans

Publication type:

Article

Glucocorticoid receptors are involved in the regulation of pulsatile urea excretion in toadfish.

Published in:

Journal of Comparative Physiology B: Biochemical, Systemic & Environmental Physiology, 2004, v. 174, n. 8, p. 649, doi. 10.1007/s00360-004-0456-y

By:

McDonald, M.;
Wood, C.;
Grosell, M.;
Walsh, P.

Publication type:

Article

Use of Spironolactone in SARS-CoV-2 ARDS Patients.

Published in:

Turkish Journal of Anaesthesiology & Reanimation, 2020, v. 48, n. 3, p. 254, doi. 10.5152/TJAR.2020.569

By:

Dumanlı, Güleren Yartaş;
Dilken, Olcay;
Ürkmez, Seval

Publication type:

Article

Characteristics of the phenotypes in prevalent and incident cases of heart failure in primary care: IBERICAN study.

Published in:

BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02506-1

By:

Cinza-Sanjurjo, Sergio;
Prieto-Díaz, Miguel Ángel;
Pallarés-Carratalá, Vicente;
Micó-Pérez, Rafael M.;
Velilla-Zancada, Sonsoles;
Barquilla-García, Alfonso;
Ginel-Mendoza, Leovigildo;
Segura-Fragoso, Antonio;
Martín-Sánchez, Vicente;
Polo-García, José

Publication type:

Article

The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women.

Published in:

International Journal of Transgender Health, 2024, v. 25, n. 3, p. 471, doi. 10.1080/26895269.2024.2323514

By:

Yang, Wenhui;
Hong, Tianpei;
Chang, Xu;
Han, Meng;
Gao, Hongwei;
Pan, Bailin;
Zhao, Zhenmin;
Liu, Ye

Publication type:

Article

Effects of antiandrogens on prolactin levels among transgender women on estrogen therapy: A systematic review.

Published in:

International Journal of Transgender Health, 2020, v. 21, n. 4, p. 391, doi. 10.1080/15532739.2020.1819505

By:

Wilson, Lisa M.;
Baker, Kellan E.;
Sharma, Ritu;
Dukhanin, Vadim;
McArthur, Kristen;
Robinson, Karen A.

Publication type:

Article

Familial Hypokalemic Periodic Paralysis Attack Following SARS -Cov -2 Infection: A Case Report.

Published in:

Archives of Anesthesiology & Critical Care, 2024, v. 10, n. 4, p. 415

By:

Yousefi-Mazhin, Ehsan;
Karballaei-Mirzahosseini, Hossein;
Sharifnia, Hamidreza;
Najafi, Atabak;
Najmeddin, Farhad;
Tofighi-Mohammadi, Mahsa;
Hassanpour, Rezvan;
Mojtahedzadeh, Mojtaba

Publication type:

Article

Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.

Published in:

Drug Development & Industrial Pharmacy, 2009, v. 35, n. 11, p. 1325, doi. 10.3109/03639040902902401

By:

Verheyen, P.;
Steffens, K.-J.;
Kleinebudde, P.

Publication type:

Article

Preparation and Characterization of Spironolactone-Loaded Gelucire Microparticles Using Spray-Drying Technique.

Published in:

Drug Development & Industrial Pharmacy, 2009, v. 35, n. 3, p. 297, doi. 10.1080/03639040802302157

By:

Yassin, Alaa Edeen B.;
Alanazi, Fars K.;
El-Badry, Mahmoud;
Alsarra, Ibrahim A.;
Barakat, Nahla S.

Publication type:

Article

Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 3, p. 319, doi. 10.1081/DDC-200052182

By:

Langguth, P.;
Hanafy, A.;
Frenzel, D.;
Grenier, P.;
Nhamias, A.;
Ohlig, T.;
Vergnault, G.;
Spahn-Langguth, H.

Publication type:

Article

Poorer Exercise Accommodation of Regional Systolic Myocardial Motion after Spironolactone Treatment in Heart Failure Patients with Preserved Ejection Fraction and Ventricular Dyssynchrony.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3827, doi. 10.3390/jcm10173827

By:

Yu, Chih-Chieh;
Chiu, Fu-Chun;
Tsai, Chia-Ti;
Wang, Yi-Chih;
Lai, Ling-Ping;
Hwang, Juey-Jen;
Lin, Jiunn-Lee

Publication type:

Article

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2958, doi. 10.3390/jcm10132958

By:

Rubel, Diana;
Zhang, Yanqin;
Sowa, Nenja;
Girgert, Rainer;
Gross, Oliver

Publication type:

Article

Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease.

Published in:

Journal of Clinical Medicine, 2018, v. 7, n. 11, p. 459, doi. 10.3390/jcm7110459

By:

Yang, Chen-Ta;
Kor, Chew-Teng;
Hsieh, Yao-Peng

Publication type:

Article

Aldosterone Antagonism Fails to Attenuate Age-Associated Left Ventricular Fibrosis.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2007, v. 62, n. 4, p. 382, doi. 10.1093/gerona/62.4.382

By:

Hyun Seok Hwang;
Cirrincione, Georgina;
Thomas, D. Paul;
McCormick, Richard J.;
Boluyt, Marvin O.

Publication type:

Article

Current Limitations in Treatment of Heart Failure: New Avenues and Treatment Options.

Published in:

Journal of Cardiovascular Electrophysiology, 2002, v. 13, p. S53, doi. 10.1111/j.1540-8167.2002.tb01954.x

By:

DREXLER, HELMUT;
FUCHS, MARTIN

Publication type:

Article

What's New in EP.

Published in:: Journal of Cardiovascular Electrophysiology, 2000, v. 11, n. 8, p. 945, doi. 10.1111/j.1540-8167.2000.tb00080.x
Publication type:: Article

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/9232065

By:

Liu, Wenjuan;
Gong, Wei;
He, Min;
Liu, Yemei;
Yang, Yeping;
Wang, Meng;
Wu, Meng;
Guo, Shizhe;
Yu, Yifei;
Wang, Xuanchun;
Sun, Fei;
Li, Yiming;
Zhou, Linuo;
Qin, Shengmei;
Zhang, Zhaoyun

Publication type:

Article

Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2017, v. 42, n. 4, p. 433, doi. 10.1111/jcpt.12525

By:

Moffett, B. S.;
Haworth, T. E.;
Wang, Y.;
Afonso, N.;
Checchia, P. A.

Publication type:

Article

Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2005, v. 30, n. 6, p. 603, doi. 10.1111/j.1365-2710.2005.00694.x

By:

Saito, M.;
Takada, M.;
Hirooka, K.;
Isobe, F.;
Yasumura, Y.

Publication type:

Article

Spironolactone use in patients with heart failure.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2004, v. 29, n. 2, p. 165, doi. 10.1111/j.1365-2710.2004.00549.x

By:

Trujillo, J.M.;
Gonyeau, M.J;
DiVall, M.V.;
Alexander, S.L.

Publication type:

Article

Undertreatment of congestive heart failure in an Australian setting.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2004, v. 29, n. 1, p. 15, doi. 10.1046/j.1365-2710.2003.00531.x

By:

Boyles, P. J.;
Peterson, G. M.;
Bleasel, M. D.;
Vial, J. H.

Publication type:

Article

The safety of spironolactone treatment in patients with heart failure.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2003, v. 28, n. 4, p. 285, doi. 10.1046/j.1365-2710.2003.00491.x

By:

Anton, C.;
Cox, A. R.;
Watson, R. D. S.;
Ferner, R. E.

Publication type:

Article

Mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo‐controlled cross‐over study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 509, doi. 10.1111/dom.13539

By:

Thuzar, Moe;
Law, Weikiat Phillip;
Dimeski, Goce;
Stowasser, Michael;
Ho, Ken K. Y.

Publication type:

Article

Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1805, doi. 10.1111/dom.12989

By:

Polyzos, Stergios A.;
Kountouras, Jannis;
Mantzoros, Christos S.;
Polymerou, Vaia;
Katsinelos, Panagiotis

Publication type:

Article

Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments.

Published in:

Pediatric Obesity, 2021, v. 16, n. 4, p. 1, doi. 10.1111/ijpo.12734

By:

Garcia‐Beltran, Cristina;
Malpique, Rita;
Carbonetto, Belen;
González‐Torres, Pedro;
Henares, Desirée;
Brotons, Pedro;
Muñoz‐Almagro, Carmen;
López‐Bermejo, Abel;
Zegher, Francis;
Ibáñez, Lourdes

Publication type:

Article

Polycystic ovary syndrome in adolescent girls.

Published in:

Pediatric Obesity, 2020, v. 15, n. 2, p. N.PAG, doi. 10.1111/ijpo.12586

By:

Ibáñez, Lourdes;
Zegher, Francis

Publication type:

Article

Towards a circulating marker of hepato‐visceral fat excess: S100A4 in adolescent girls with polycystic ovary syndrome — Evidence from randomized clinical trials.

Published in:

Pediatric Obesity, 2019, v. 14, n. 5, p. N.PAG, doi. 10.1111/ijpo.12500

By:

Malpique, Rita;
Garcia‐Beltran, Cristina;
Ibáñez, Lourdes;
Sánchez‐Infantes, David;
Taxerås, Siri D.;
López‐Bermejo, Abel;
Zegher, Francis

Publication type:

Article

Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction.

Published in:

British Journal of Pharmacology, 2006, v. 148, n. 1, p. 46, doi. 10.1038/sj.bjp.0706700

By:

Sønder, Søren Ulrik Salling;
Mikkelsen, Marianne;
Rieneck, Klaus;
Hedegaard, Chris Juul;
Bendtzen, Klaus

Publication type:

Article

Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1+minK channels.

Published in:

British Journal of Pharmacology, 2005, v. 146, n. 1, p. 146, doi. 10.1038/sj.bjp.0706302

By:

G&ómez, Ricardo;
N&ú&ñez, Luc&ía;
Caballero, Ricardo;
Vaquero, Miguel;
Tamargo, Juan;
Delp&ón, Eva

Publication type:

Article

Antiandrogen therapy in hidradenitis suppurativa: finasteride for females.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 1, p. 86, doi. 10.1111/ced.14847

By:

Babbush, K. M.;
Andriano, T. M.;
Cohen, S. R.

Publication type:

Article

Spironolactone in dermatology: uses in acne and beyond.

Published in:

Clinical & Experimental Dermatology, 2020, v. 45, n. 8, p. 986, doi. 10.1111/ced.14340

By:

Searle, T. N.;
Al‐Niaimi, F.;
Ali, F. R.

Publication type:

Article

Spironolactone therapy for hidradenitis suppurativa.

Published in:

Clinical & Experimental Dermatology, 2020, v. 45, n. 4, p. 464, doi. 10.1111/ced.14119

By:

Quinlan, C.;
Kirby, B.;
Hughes, R.

Publication type:

Article

What's new in acne? An analysis of systematic reviews published in 2009-2010.

Published in:

Clinical & Experimental Dermatology, 2011, v. 36, n. 2, p. 119, doi. 10.1111/j.1365-2230.2010.03921.x

By:

Smith, E. V.;
Grindlay, D. J. C.;
Williams, H. C.

Publication type:

Article

Lichenoid drug eruption induced by spironolactone.

Published in:

Clinical & Experimental Dermatology, 1998, v. 23, n. 1, p. 43

By:

Clark, C.;
Douglas, W. S.

Publication type:

Article

Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.

Published in:

2022

By:

Roughead, Elizabeth E.;
Kerr, Mhairi;
Moffat, Anna;
Kassie, Gizat M.;
Pratt, Nicole

Publication type:

journal article

Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).

Published in:

2007

By:

Hauben, Manfred;
Reich, Lester;
Gerrits, Charles M.;
Madigan, David

Publication type:

journal article

Etiology of Pain and Its Association with Quality of Life among Patients with Heart Failure.

Published in:

Journal of Palliative Medicine, 2016, v. 19, n. 12, p. 1254, doi. 10.1089/jpm.2016.0095

By:

Pantilat, Steven Z.;
O'Riordan, David L.;
Rathfon, Megan A.;
Dracup, Kathleen A.;
De Marco, Teresa

Publication type:

Article

Formulation and Evaluation of Spironolactone Microspheres using natural and synthetic polymers as a Carrier.

Published in:

International Journal of Pharmacy & Life Sciences, 2014, v. 5, n. 10, p. 3887

By:

Maithani, Jyoti;
Singh, Vikram;
Juyal, Divya;
Kalra, Kapil;
Rawat, Geeta

Publication type:

Article

Study of drugs used in cerebral edema in patients with stroke at a tertiary care center.

Published in:

National Journal of Physiology, Pharmacy & Pharmacology, 2017, v. 7, n. 2, p. 151, doi. 10.5455/njppp.2017.7.0824619082016

By:

Kumar B., Praveen;
Scandashree K.;
Udaykumar, Padmaja

Publication type:

Article

Spironolactone dose-dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit-1.

Published in:

Molecular Medicine Reports, 2019, v. 19, n. 5, p. 3622

By:

Wang, Ping;
Quan, Zhengli;
Luo, Dingshi;
Chen, Wangshan;
Peng, Dan

Publication type:

Article

Investigation into hippocampal nerve cell damage through the mineralocorticoid receptor in mice.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 5, p. 7211, doi. 10.3892/mmr.2015.4406

By:

KENROH SASAKI;
FUMIHIKO YOSHIZAKI

Publication type:

Article

Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 5, p. 6849, doi. 10.3892/mmr.2015.4295

By:

ZHUO LI;
LI ZHANG;
WEI SHI;
YUANHAN CHEN;
HONG ZHANG;
SHUANGXIN LIU;
XINLING LIANG;
TING LING;
CHUNPING YU;
ZHONGSHUN HUANG;
XIAOFAN TAN;
XINCHEN ZHAO;
ZHIMING YE;
BIN ZHANG;
WENJIAN WANG;
RUIZHAO LI;
JIANCHAO MA

Publication type:

Article

MINERALOCORTICOID RECEPTOR ANTAGONISTS FOR TREATMENT OF HYPERTENSION AND HEART FAILURE.

Published in:

Methodist DeBakey Cardiovascular Journal, 2015, v. 11, n. 4, p. 235, doi. 10.14797/mdcj-11-4-235

By:

Sica, Domenic A.

Publication type:

Article

Renin Angiotensin Aldosterone System Blockade in Practice: A Clinical Perspective.

Published in:

2014

By:

Misra, Virendra K.;
Wael Al-Mahmeed

Publication type:

Opinion

In patients with acute MI, spironolactone did not reduce cardiac events at 3 y.

Published in:

Annals of Internal Medicine, 2025, v. 178, n. 3, p. JC33, doi. 10.7326/ANNALS-25-00335-JC

By:

Kelsey, Michelle D.;
Newby, L. Kristin

Publication type:

Article

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome.

Published in:

International Journal of Endocrinology, 2018, p. 1, doi. 10.1155/2018/4192940

By:

Díaz, Marta;
Gallego-Escuredo, José Miguel;
López-Bermejo, Abel;
de Zegher, Francis;
Villarroya, Francesc;
Ibáñez, Lourdes

Publication type:

Article